|
|
Yasuo Terauchi, Iseki Takamoto, Naoto Kubota, Junji Matsui, Ryo Suzuki, Kajuro Komeda, Akemi Hara, Yukiyasu Toyoda, Ichitomo Miwa, Shinichi Aizawa, Shuichi Tsutsumi, Yoshiharu Tsubamoto, Shinji Hashimoto, Kazuhiro Eto, Akinobu Nakamura, Mitsuhiko Noda, Kazuyuki Tobe, Hiroyuki Aburatani, Ryozo Nagai, Takashi Kadowaki
J Clin Invest. 2007;
117(1):246
doi:10.1172/JCI17645
Abstract |
Full text
| PDF
| Supplemental material

G
lucokinase (Gck) functions as a glucose sensor for insulin secretion, and in mice fed standard chow, haploinsufficiency of β cell–specific Gck (Gck+/–) causes impaired insulin secretion to glucose, although the animals have a normal β cell mass. When fed a high-fat (HF) diet, wild-type mice showed marked β cell hyperplasia, whereas Gck+/– mice demonstrated decreased β cell replication and insufficient β cell hyperplasia despite showing a similar degree of insulin resistance. DNA chip analysis revealed decreased insulin receptor substrate 2 (Irs2) expression in HF diet–fed Gck+/– mouse islets compared with wild-type islets. Western blot analyses confirmed upregulated Irs2 expression in the islets of HF diet–fed wild-type mice compared with those fed standard chow and reduced expression in HF diet–fed Gck+/– mice compared with those of HF diet–fed wild-type mice. HF diet–fed Irs2+/– mice failed to show a sufficient increase in β cell mass, and overexpression of Irs2 in β cells of HF diet–fed Gck+/– mice partially prevented diabetes by increasing β cell mass. These results suggest that Gck and Irs2 are critical requirements for β cell hyperplasia to occur in response to HF diet–induced insulin resistance.
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal.
Not all publishers participate in CrossRef, so this information is not comprehensive.
Additionally, data may not reflect the most current citations to this article,
and the data may differ from citation information available from other sources
(for example, Google Scholar, Web of Science, and Scopus).
About CrossRef
| Title and authors |
Publication |
Year |
. |
Miglitol administered before breakfast increased plasma active glucagon-like peptide-1 (GLP-1) levels after lunch in patients with type 2 diabetes treated with sitagliptin
Kazutaka Aoki, Hiroshi Kamiyama, Kouichiro Yoshimura, Makoto Shibuya, Kiyomi Masuda, Yasuo Terauchi |
Acta Diabetol |
2011 |
.
|
Chronic glucokinase activation reduces glycaemia and improves glucose tolerance in high-fat diet fed mice
Maria Sörhede Winzell, Matthew Coghlan, Brendan Leighton, Georgia Frangioudakis, David M. Smith, Leonard H. Storlien, Bo Ahrén |
EUROP J PHARMACOL |
2011 |
.
|
Exendin-4 regulates GLUT2 expression via the CaMKK/CaMKIV pathway in a pancreatic β-cell line
Ke Chen, Xiao Yu, Koji Murao, Hitomi Imachi, Junhua Li, Tomie Muraoka, Hisashi Masugata, Guo-Xing Zhang, Ryoji Kobayashi, Toshihiko Ishida |
Metabolism |
2011 |
.
|
Ezetimibe decreases SREBP-1c expression in liver and reverses hepatic insulin resistance in mice fed a high-fat diet
Tomonori Muraoka, Kazutaka Aoki, Tomoyuki Iwasaki, Kazuaki Shinoda, Akinobu Nakamura, Hiroyuki Aburatani, Shuuichi Mori, Kumpei Tokuyama, Naoto Kubota, Takashi Kadowaki |
Metabolism |
2011 |
.
|
Upregulation of -cell genes and improved function in rodent islets following chronic glucokinase activation
D. Gill, K. J. Brocklehurst, H. W. G. Brown, D. M. Smith |
J Mol Endocrin |
2011 |
.
|
Effect of long-term treatment with a small-molecule glucokinase activator on glucose metabolism, lipid profiles and hepatic function
Akinobu Nakamura, Hiroko Shimazaki, Sumika Ohyama, Junichi Eiki, Yasuo Terauchi |
J Diabetes Invest |
2011 |
.
|
|
|
|